The Role, Pathoimmunobiology, and Translational Implications of A Novel Engineered Cytokine Fusion Protein Targeting the Interleukin-2 (IL-2) Pathway
Focus on Nemvaleukin in Mucosal Melanoma and Ovarian Cancer